Science Explorer Back to mapMap
Discussion
Hospital / health system · Fayetteville · United States

Highlands Oncology Group

highlandsoncologygroup.comROR OpenAlex
Research works
77
▲ 18% vs 2018-21
Citations
1.4k
18.4 per fractional work
Top-10% rate
12.0%
all institutions 10.0%
Open access
34%
world 40%
International
29%
world 18%
Highlands Oncology Group

Not ranked overall: Highlands Oncology Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Highlands Oncology Group work in?

In 2022-now, 52% of research at Highlands Oncology Group is in Health Sciences, 20% in Physical Sciences. Its largest fields are Medicine (51%), Biochemistry, Genetics and Molecular Biology (15%), Chemistry (7%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 13 fractional works · 52.1% of its workMedicine: 12 fractional works · 51.1% of its workOncology: 4 fractional works · 16.3% of its workPulmonary and Respiratory Medicine: 2 fractional works · 10.2% of its workSurgery: 1 fractional works · 4.7% of its workEpidemiology: 1 fractional works · 3.1% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.6% of its workHematology: 0 fractional works · 1.7% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.7% of its workNeurology: 0 fractional works · 1.6% of its workOphthalmology: 0 fractional works · 1.4% of its workEmergency Medicine: 0 fractional works · 1.4% of its workFamily Practice: 0 fractional works · 1.4% of its workRheumatology: 0 fractional works · 0.9% of its workGenetics: 0 fractional works · 0.9% of its workGastroenterology: 0 fractional works · 0.7% of its workPathology and Forensic Medicine: 0 fractional works · 0.6% of its workInfectious Diseases: 0 fractional works · 0.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workPhysiology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 1.0% of its workSpeech and Hearing: 0 fractional works · 0.5% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workHealth Information Management: 0 fractional works · 0.2% of its workPhysical Sciences: 5 fractional works · 20.1% of its workChemistry: 2 fractional works · 7.0% of its workOrganic Chemistry: 2 fractional works · 7.0% of its workEnvironmental Science: 1 fractional works · 4.8% of its workEcology: 1 fractional works · 2.8% of its workEnvironmental Engineering: 0 fractional works · 2.1% of its workEngineering: 1 fractional works · 4.0% of its workAutomotive Engineering: 0 fractional works · 2.1% of its workControl and Systems Engineering: 0 fractional works · 0.9% of its workCivil and Structural Engineering: 0 fractional works · 0.7% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMaterials Science: 0 fractional works · 2.1% of its workMaterials Chemistry: 0 fractional works · 2.1% of its workComputer Science: 0 fractional works · 1.5% of its workComputational Theory and Mathematics: 0 fractional works · 0.8% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.5% of its workArtificial Intelligence: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.7% of its workGeometry and Topology: 0 fractional works · 0.7% of its workLife Sciences: 5 fractional works · 19.8% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 15.1% of its workMolecular Biology: 2 fractional works · 10.1% of its workGenetics: 1 fractional works · 2.2% of its workCancer Research: 0 fractional works · 2.0% of its workBiotechnology: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 1 fractional works · 2.4% of its workImmunology: 1 fractional works · 2.4% of its workAgricultural and Biological Sciences: 0 fractional works · 1.4% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.7% of its workPlant Science: 0 fractional works · 0.7% of its workNeuroscience: 0 fractional works · 1.0% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.0% of its workSocial Sciences: 2 fractional works · 8.0% of its workArts and Humanities: 1 fractional works · 3.3% of its workLiterature and Literary Theory: 0 fractional works · 1.6% of its workReligious studies: 0 fractional works · 1.4% of its workPhilosophy: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 1 fractional works · 3.2% of its workEconomics and Econometrics: 1 fractional works · 3.2% of its workSocial Sciences: 0 fractional works · 1.5% of its workPolitical Science and International Relations: 0 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workALL ITS WORKHighlandsOncology Group24fractional works, 2022-now
Life Sciences20%Physical Sciences20%Health Sciences52%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine1251.1%
    2. Health Professions01.0%
    1. Chemistry27.0%
    2. Environmental Science14.8%
    3. Engineering14.0%
    4. Materials Science02.1%
    5. Computer Science01.5%
    6. Mathematics00.7%
    1. Biochemistry, Genetics and Molecular Biology415.1%
    2. Immunology and Microbiology12.4%
    3. Agricultural and Biological Sciences01.4%
    4. Neuroscience01.0%
    1. Arts and Humanities13.3%
    2. Economics, Econometrics and Finance13.2%
    3. Social Sciences01.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.29× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.83× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 2.36× its world share, 1 worksImmunology and Micro…Neuroscience: 0.62× its world share, 0 worksNeuroscienceChemistry: 4.47× its world share, 2 worksChemistryComputer Science: 0.19× its world share, 0 worksComputer ScienceEngineering: 0.26× its world share, 1 worksEngineeringEnvironmental Science: 0.97× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.59× its world share, 0 worksMaterials ScienceMathematics: 0.59× its world share, 0 worksMathematicsHealth Professions: 0.37× its world share, 0 worksHealth ProfessionsMedicine: 2.66× its world share, 12 worksMedicineArts and Humanities: 1.13× its world share, 1 worksArts and HumanitiesEconomics, Econometrics and Finance: 1.49× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.12× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 4.5×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Chemistry4.47×2 works
  2. Biochemistry, Genetics and Molecular Biology2.83×4 works
  3. Medicine2.66×12 works
  4. Immunology and Microbiology2.36×1 works
  5. Economics, Econometrics and Finance1.49×1 works
  6. Arts and Humanities1.13×1 works
  7. Environmental Science0.97×1 works
  8. Neuroscience0.62×0 works
  9. Materials Science0.59×0 works
  10. Mathematics0.59×0 works
  11. Health Professions0.37×0 works
  12. Agricultural and Biological Sciences0.29×0 works
  13. Engineering0.26×1 works
  14. Computer Science0.19×0 works
  15. Social Sciences0.12×0 works

Who are the top researchers at Highlands Oncology Group?

Ranked on the quality score, Joseph Thaddeus Beck, Eric Scott Schaefer and Thaddeus Beck lead among researchers whose main affiliation is Highlands Oncology Group.

  1. 1 Joseph Thaddeus Beck United States · #63,338 worldwide 14k citations · 330 works
  2. 2 Eric Scott Schaefer United States · #1,104,106 worldwide 3.8k citations · 79 works
  3. 3 Thaddeus Beck United States · #1,370,190 worldwide 1.6k citations · 30 works
  4. 4 Patrick M. Travis United States · #1,450,388 worldwide 625 citations · 19 works
  5. 5 Joseph T. Beck United States · #2,424,189 worldwide 420 citations · 18 works
All ranked researchers at Highlands Oncology Group

What are the most cited papers from Highlands Oncology Group?

The most cited paper from Highlands Oncology Group is "Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer" (José Baselga et al., 2011), with 2,868 citations. Next come "Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer" (876) and "Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years" (656).

Most cited papers
#PaperReleasedCitations
1 Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer José Baselga et al. · New England Journal of Medicine Open access 7 Dec 2011 2,868
2 Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer Dennis J. Slamon et al. · New England Journal of Medicine Open access 11 Dec 2019 876
3 Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years Paul Edward Goss, James N. Ingle, Kathleen I. Pritchard et al. · New England Journal of Medicine Open access 5 Jun 2016 656
4 MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study Paolo A. Ascierto, Dirk Schadendorf, Carola Berking et al. · The Lancet Oncology 12 Feb 2013 647
5 Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer Mary Lenora Disis, Matthew Hiram Taylor, Karen L. Kelly et al. · JAMA Oncology Open access 24 Jan 2019 437
All 60 most cited papers, with filters and sorting

Which keywords describe research at Highlands Oncology Group?

By fractional works in 2022-now, weighted toward what it does more of than the world: Breast Cancer, Metastatic Breast Cancer, Chemotherapy, Cell Cycle Control, Synthesis, CDK4/6 Inhibitors, Palbociclib and Prognostic Factors.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Breast Cancer3▲ 46×5 topics
  2. Metastatic Breast Cancer2▲ 172×2 topics
  3. Chemotherapy2▲ 11×10 topics
  4. Cell Cycle Control2▲ 221×2 topics
  5. CDK4/6 Inhibitors2▲ 240×1 topic
  6. Palbociclib2▲ 240×1 topic
  7. Synthesis2▲ 19×4 topics
  8. Prognostic Factors2▲ 14×9 topics
  9. Targeted Therapy1▲ 23×4 topics
  10. Quality of Life1▲ 3.5×3 topics
  11. Clinical Trials1▲ 6.7×2 topics
  12. Immunotherapy1▲ 6.1×10 topics
  13. Radiotherapy1▲ 12×6 topics
  14. Biflavonoids1▲ 717×1 topic
  15. Cytotoxicity1▲ 31×2 topics
  16. Diterpenoids1▲ 369×1 topic
  17. Drug Discovery1▲ 18×2 topics

Which research topics does Highlands Oncology Group publish most on?

By volume in 2022-now: Advanced Breast Cancer Therapies, Biological Activity of Diterpenoids and Biflavonoids, Cancer Treatment and Pharmacology and Economic and Financial Impacts of Cancer.

Advanced Breast Cancer T…2Advanced Breast Cancer Therapies: 2 fractional worksBiological Activity of Diterpenoids and Biflavonoids: 1 fractional worksCancer Treatment and Pharmacology: 1 fractional worksEconomic and Financial Impacts of Cancer: 1 fractional worksResearch studies in Vietnam: 1 fractional worksMulticomponent Synthesis of Heterocycles: 1 fractional worksHER2/EGFR in Cancer Rese…1HER2/EGFR in Cancer Research: 1 fractional worksLung Cancer Treatments a…1Lung Cancer Treatments and Mutations: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksLung Cancer Research Stu…0Lung Cancer Research Studies: 0 fractional works
Pulmonary and Respiratory MedicineMolecular BiologyOncologyEconomics and Econometrics2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  2. 2 Biological Activity of Diterpenoids and Biflavonoids Molecular Biology 1 works
  3. 3 Cancer Treatment and Pharmacology Oncology 1 works
  4. 4 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  5. 5 Research studies in Vietnam Ecology 1 works
  6. 6 Multicomponent Synthesis of Heterocycles Organic Chemistry 1 works
  7. 7 HER2/EGFR in Cancer Research Oncology 1 works
  8. 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  9. 9 Cancer Immunotherapy and Biomarkers Oncology 1 works
  10. 10 Lung Cancer Research Studies Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.0%not open66.0%

World: 40% of research is openly available.

with international co-authors29.0%domestic only71.0%

World: 18% is written across borders.

How has Highlands Oncology Group's research output changed?

Output in 2022-2025 was 18% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Highlands Oncology Group as a percentage of every work published that year, 0.000078% in 2024.

still counting0.00020%0.00040%Highlands Oncology Group0.000100% in 202519801990200020102020

Fractional works of Highlands Oncology Group over all fractional works that year. How the balance of science has shifted.

Other research institutions in Fayetteville

All research institutions in Fayetteville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Highlands Oncology Group. Posts are plain text and can be reported.